L26/O-337 Monogenic causes of recurrent euploid pregnancy loss identified by whole-exome sequencing of products of conception: a retrospective cohort study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.335 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von F. Awad und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can whole-exome sequencing (WES) of products-of-conception (POC) identify monogenic causes in couples classified as having unexplained euploid recurrent pregnancy loss (RPL) after standard evaluation? Summary answer A substantial proportion of pregnancies classified as unexplained euploid RPL are attributable to single-gene disorders identifiable by WES of POC. What is known already Recurrent pregnancy loss (RPL), defined as two or more miscarriages, affects up to 5% of couples. Chromosomal microarray (CMA) analysis detects aneuploidy in approximately 58% of miscarriages and, when combined with standard clinical evaluation, explains >90% of cases overall. Consequently, couples with euploid POC and otherwise normal evaluations are classified as having truly unexplained RPL. In this subgroup, monogenic causes of embryonic or fetal lethality may remain undetected using conventional approaches. Study design, size, duration This retrospective cohort study evaluated nine couples with ≥2 pregnancy losses, all occurring during the first or second trimester, and classified as having truly unexplained euploid RPL following comprehensive standard investigation between December 2024 and December 2025. Cases were referred for molecular genetic evaluation by multiple gynecologists and infertility centers. Participants/materials, setting, methods All couples underwent a complete RPL work-up, including parental karyotyping. DNA was extracted from POC and parental blood samples. CMA on POC was used for most cases to exclude aneuploidy/polyploidy. WES was performed on POC in all cases, with whole-genome sequencing (WGS) in one case. Trio-based exome analysis was undertaken in 3 families. Variant prioritization considered allele frequency, predicted functional impact, inheritance pattern, and phenotype–gene correlation, with segregation analysis where parental DNA was available. Main results and the role of chance Pathogenic, likely pathogenic, or variants of uncertain significance (VUS) with strong evidence of pathogenicity explaining embryonic or fetal lethality were identified in five of nine families (55.6%). Trio-based exome analysis identified a homozygous missense GBE1 variant (c.467G>A p.Arg156His) in the POC, associated with lethal glycogen storage disease type IV; following this diagnosis, the couple underwent preimplantation genetic testing for monogenic disorders (PGT-M) and preimplantation genetic testing for aneuploidy (PGT-A), resulting in an ongoing second-trimester pregnancy. In another family, trio-based exome identified a novel homozygous truncating variant in APAF1 (c.951_953del p.Cys317*) in two independent products of conception; WES was performed in one POC and WGS in the other, consistent with recurrent embryonic lethality due to impaired apoptosis; the couple is pursuing PGT-M and PGT-A. Two apparently unrelated couples carried the same homozygous likely pathogenic POMT2 variant (c.1990C>T p.His664Tyr) in the POC, associated with severe fetal central nervous system malformations and second-trimester loss. In an additional family, trio-based exome identified compound heterozygous NUP188 variants (c.1797-2A>G, likely pathogenic; and c.3034A>G p.Asn1012Asp, VUS) in the POC associated with Sandestig–Stefanova syndrome, a lethal autosomal recessive developmental disorder, and the couple is pursuing PGT-M and PGT-A. No causative variants were identified in four families. Limitations, reasons for caution The cohort size is limited, and functional validation was not performed. Some disease-causing variants may reside in genes not yet implicated in prenatal lethality, and unresolved cases may require WGS or long-read sequencing and future gene–disease discovery to establish molecular etiology. Wider implications of the findings These findings demonstrate that a significant proportion of cases labeled as truly unexplained euploid RPL are attributable to single-gene disorders. Incorporating sequencing of products of conception after normal CMA may redefine unexplained RPL, improve recurrence-risk counselling, and enable precision reproductive strategies, including targeted PGT. Trial registration number No
Zitieren
APA
Awad, F., Kassem, H., Sorgholi, F., Abughoush, L., Abeddayem, O., Nassan, M., & Abukhaizaran, R. (2026). L26/O-337 Monogenic causes of recurrent euploid pregnancy loss identified by whole-exome sequencing of products of conception: a retrospective cohort study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.335
Vancouver
Awad F, Kassem H, Sorgholi F, Abughoush L, Abeddayem O, Nassan M, et al. L26/O-337 Monogenic causes of recurrent euploid pregnancy loss identified by whole-exome sequencing of products of conception: a retrospective cohort study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.335
BibTeX
@article{Awad2026,
author = {Awad, F. and Kassem, H. and Sorgholi, F. and Abughoush, L. and Abeddayem, O. and Nassan, M. and Abukhaizaran, R.},
title = {L26/O-337 Monogenic causes of recurrent euploid pregnancy loss identified by whole-exome sequencing of products of conception: a retrospective cohort study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.335}
}
EUVIMED